Challenge: The client required a PCBA for a life-critical Cardiac Monitor that demanded absolute reliability and signal precision. The design featured fine-pitch BGA components (0.4mm) and sensitive analog circuits, which posed significant challenges for soldering integrity and electromagnetic interference (EMI) control. Additionally, the project required strict adherence to IPC-A-610 Class 3 standards and full component traceability to satisfy FDA 21 CFR Part 820 regulations.

Solution: We utilized a dedicated ISO 13485-certified cleanroom environment and employed Nitrogen (N2) reflow soldering to ensure robust solder joints for the fine-pitch BGAs. Our quality control process included 100% X-Ray inspection and In-Circuit Testing (ICT) to verify electrical performance. To meet FDA requirements, we implemented a comprehensive MES (Manufacturing Execution System), tracking the lot code and date code of every component for full lifecycle traceability.

Result: The project achieved a 99.98% First Pass Yield (FPY) in mass production, with zero soldering defects detected. The detailed traceability reports and quality documentation enabled the client to pass the FDA audit smoothly on the first attempt. This success reduced their time-to-market by 15% and established us as their primary manufacturing partner for future medical devices.